3/23/2021 | IG | Moody's downgrades Astellas
|
3/5/2020 | IG | Moody's downgrades Astellas
|
12/6/2019 | IG | Moody’s reviews Astellas Pharma for downgrade
|
12/3/2014 | IG | Moody’s cuts five Japanese corporates to A1
|
6/9/2010 | CV | OSI 2% notes are convertible through July 8 due to fundamental change
|
3/18/2009 | SS | CV Therapeutics' board in favor of merger with Gilead Sciences
|
3/16/2009 | SS | Astellas Pharma drops bid for CV Therapeutics
|
3/16/2009 | SS | Market Commentary: Agrium may increase CF Industries bid; CV Therapeutics, Gilead face few regulatory concerns
|
3/12/2009 | SS | Market Commentary: Genentech OKs latest bid; bidding war on way for CV Therapeutics; CF Industries pushes for Terra deal
|
3/12/2009 | SS | CV Therapeutics board rejects Astellas Pharma tender offer
|
2/27/2009 | SS | Astellas Pharma begins tender offer for CV Therapeutics, files lawsuit against company
|
2/27/2009 | SS | Market Commentary: Astellas takes CV offer hostile; Agrium considered stronger suitor in bid for CF Industries
|
2/25/2009 | SS | Market Commentary: Terra bid moot on Agrium's offer for CF Industries; Senate comments continue for Live Nation merger
|
2/2/2009 | SS | Market Commentary: Second Amylin shareholder wants changes; analysts predict higher bid for CV Therapeutics
|
1/28/2009 | SS | CV Therapeutics turns down Astellas Pharma for second time
|
1/28/2009 | SS | Market Commentary: CV Therapeutics could open door to higher bid; CF Industries considers options after Terra says no
|
1/27/2009 | SS | Astellas Pharma seeks to acquire CV Therapeutics
|
1/27/2009 | SS | Market Commentary: Roche bid for Genentech predicted to increase; CV not likely to bite at Astellas offer, analyst says
|
7/18/2006 | BT | Theravance, Astellas add Japan to collaboration on investigational antibiotic
|
7/7/2006 | BT | Cardiome, development partner meet with FDA, to follow up on refusal-to-file letter for RSD1235
|
5/16/2006 | BT | Theravance completes enrollment in phase 3 clinical program with antibiotic telavancin
|
4/3/2006 | BT | Astellas to buy Amevive from Biogen Idec
|
3/31/2006 | BT | Cardiome, Astellas file NDA for atrial fibrillation drug RSD1235
|
2/2/2006 | BT | AtheroGenics, Astellas extend collaboration for organ transplant rejection agent
|
12/30/2005 | BT | Astellas' Vaprisol receives FDA OK for treatment of electrolyte dilution
|
11/30/2005 | BT | XenoPort, Astellas enter license agreement for XP13512 in Asia
|
10/19/2005 | BT | Cardiome, Astellas announce open-label study of atrial fibrillation drug
|